跳至主要内容
临床试验/IRCT20231008059655N1
IRCT20231008059655N1招募中3 期

?Comparison of the effect of adding nebulized low molecular weight heparin to the treatment of patients with Covid 19 who are treated with Remdesivir on an outpatient basis compared to the usual treatment during five days

Ahvaz University of Medical Sciences0 个研究点目标入组 42 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Positive Covid-19 test
  • Patients who are treated on an outpatient basis

排除标准

  • Patients with poor general condition and hospitalization in the emergency room
  • Patients with acute medical problems

研究者

相似试验